Trademarkia Logo

Canada

C$
SOBI
ADVERTISED

on 24 Jan 2025

Last Applicant/ Owned by

Swedish Orphan Biovitrum AB (publ)

SE-112 76 Stockholm

SE

Serial Number

2167461 filed on 1st Feb 2022

Registration Number

TMA1285999 registered on 24th Jan 2025

Registration expiry Date

16th May 2034

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

SOBI

Trademark usage description

medical and pharmaceutical preparations for the treatment of blood disorders, cancer, immunologic diseases, namely, autoimmune diseases and immunologi Read More

Classification Information


Class [005]
Medical and pharmaceutical preparations for the treatment of blood disorders, cancer, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases, vascular diseases, inflammatory muscle diseases and disorders, and cardiovascular diseases; medical drugs for human use for the treatment of blood disorders, cancer, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases, vascular diseases, inflammatory muscle diseases and disorders, and cardiovascular diseases; dietetic and nutritional preparations and substances adapted for medical use namely dietetic substances consisting of vitamins, minerals, amino acids and trace elements, nutritional supplement meal replacement bars for boosting energy, nutritional supplements for general health and well-being; diagnostic preparations for medical use namely diagnostic preparations for medical laboratory use, diagnostic reagents for medical diagnostic use; diagnostic test reagents for medical use


Classification kind code

10

Class [010]
Surgical instruments; medical devices namely hypodermic needles and syringes; testing apparatus, namely, diagnostic biomolecule and DNA sequence detection devices for medical purposes for use in the diagnosis of blood disorders, cancer, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases, vascular diseases, inflammatory muscle diseases and disorders, and cardiovascular diseases; diagnostic biomarker testing apparatus for medical purposes for use in diagnosis of blood disorders, cancer, immunologic diseases, namely, autoimmune diseases and immunologic deficiency syndromes, diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases, vascular diseases, inflammatory muscle diseases and disorders, and cardiovascular diseases


Classification kind code

10

Class [035]
Retail sales services in the field of pharmaceuticals, medical preparations, vaccines, natural remedies, diagnostics and medical devices; import-export agencies; sales promotion for others in the field of pharmaceuticals, medical preparations, vaccines, natural remedies, diagnostics and medical devices.


Classification kind code

10

Class [042]
Medical research; biological and chemical research; research and development of new medicines and medical preparations; medical research laboratories and chemical laboratories; scientific and industrial research.


Classification kind code

10

Mark Details


Serial Number

2167461

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 8th Jun 2023
Search Recorded
Submitted for opposition 20
on 8th Jun 2023
Examiner's First Report
Submitted for opposition 223
on 8th Jun 2023
Total Provisional Refusal
Submitted for opposition 256
on 19th Dec 2022
Notification of Possible Opposition Sent
Submitted for opposition 48
on 18th Mar 2022
Agent Changed
Submitted for opposition 257
on 17th Feb 2022
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 17th Feb 2022
Created
Submitted for opposition 31
on 17th Feb 2022
Formalized
Submitted for opposition 30
on 1st Feb 2022
Filed
Submitted for opposition 228
on 16th May 2014
International Registration